We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Velan Inc | TSX:VLN | Toronto | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -2.19% | 11.18 | 11.11 | 11.25 | 11.40 | 11.11 | 11.16 | 6,580 | 21:01:00 |
FOURTH QUARTER HIGHLIGHTS:
YEAR-END HIGHLIGHTS:
FINANCIAL RESULTS(‘000s of U.S. dollars, excluding per share amounts) | Three-month periods ended | Fiscal years ended | |||||||
Feb. 29, 2024 | Feb. 28, 2023 | Feb. 29, 2024 | Feb. 28, 2023 | ||||||
Sales | $117,894 | $115,141 | $346,816 | $370,429 | |||||
Gross profit | $38,384 | $39,945 | $93,207 | $112,465 | |||||
Gross margin | 32.6% | 34.7% | 26.9% | 30.4% | |||||
Net loss | ($2,083) | ($47,164) | ($19,737) | ($55,453) | |||||
per share - basic and diluted | ($0.10) | ($2.18) | ($0.91) | ($2.57) | |||||
Adjusted EBITDA | $19,879 | $16,468 | $17,780 | $21,092 | |||||
Adjusted net income (loss) | $8,944 | $8,790 | ($7,918) | $501 | |||||
per share - basic and diluted | $0.41 | $0.41 | ($0.37) | $0.02 | |||||
Weighted average share outstanding (‘000s) | 21,586 | 21,586 | 21,586 | 21,586 |
“Velan concluded fiscal 2024 with strong fourth quarter results, marked by heightened sales volume and healthy profit margins on improved quality of execution,” said James A. Mannebach, Chairman and CEO of Velan. “In addition, robust bookings during the period further increased our backlog to $491.5 million at year-end. Given the value of orders to be shipped over the next 12 months, we expect sales growth in fiscal 2025. As a supplier of critical equipment to essential industries, Velan is well positioned to capture growth opportunities driven by the ongoing energy transition and expand its reach in the flow control industry based on an agile workforce, global presence and strong brand recognition.”
“Fueled by a net cash position, Velan’s strong balance sheet will allow the Company to fund its current operations and pursue re-investment to expand its global reach. Over the longer term, we remain committed to building shareholder value through sales and cash flow growth,” added Rishi Sharma, Chief Financial and Administrative Officer of Velan.
BOOKINGS AND BACKLOG(‘000s of U.S. dollars, excluding ratio) | Three-month periods ended | Fiscal years ended | |||||||||||
Feb. 29, 2024 | Feb. 28, 2023 | Feb. 29, 2024 | Feb. 28, 2023 | ||||||||||
Backlog | $491,525 | $464,337 | |||||||||||
for delivery within the next 12 months | $360,669 | $307,991 | |||||||||||
Bookings | $132,825 | $87,085 | $374,454 | $353,176 | |||||||||
Book-to-bill ratio | 1.13 | 0.76 | 1.08 | 0.95 |
As at February 29, 2024, the backlog stood at $491.5 million, up $27.2 million, or 5.9%, from $464.3 million a year earlier reflecting strong fourth quarter bookings. As at February 29, 2024, 73.4% of the backlog, representing orders of $360.7 million, is deliverable in the next 12 months, versus 66.3% of last year’s backlog. Currency movements had a positive effect of $5.6 million on the backlog during the year.
Bookings for the fourth quarter of fiscal 2024 amounted to $132.8 million, up 52.5% over bookings of $87.1 million a year earlier. The increase is mainly attributable to strong oil and gas bookings recorded by the Company’s Italian operations and to higher orders recorded by North American operations, partially offset by the timing of orders for the French subsidiary following strong bookings in the prior year. Currency movements had a positive effect of $3.8 million on bookings during the quarter.
As a result of bookings outpacing sales, the Company’s book-to-bill ratio was 1.13 in the fourth quarter of fiscal 2024, compared to 0.76 in the corresponding period of fiscal 2023.
Fiscal 2024 bookings reached $374.5 million, an increase of $21.3 million or 6.0% compared to the previous year. As a result of bookings outpacing sales for the fiscal year, the Company’s book-to-bill ratio was 1.08 in fiscal 2024, compared with 0.95 in fiscal 2023.
FISCAL 2024 FOURTH QUARTER RESULTS
Sales reached $117.9 million, up $2.8 million or 2.4% from last year. The variation is mostly attributable to stronger shipments from the Company’s International operations. These factors were partially offset by lower shipments from North American operations and shipping delays due to the situation in the Red Sea. Currency movements had a $1.7 million positive effect on sales for the quarter.
Gross profit was $38.4 million, versus $39.9 million a year ago. The variation reflects a less favorable product mix this year compared to last due to the execution of certain low margin projects. Last year’s gross profit also benefitted from a favorable revaluation of the inventory provision based on new estimates relating to changes in market demand. As a percentage of sales, gross profit was 32.6%, versus 34.7% last year.
Administration costs reached $33.1 million, compared to $80.8 million last year. This year’s administration costs include a $10.0 million asbestos provision adjustment and restructuring charges of $1.3 million mostly consisting of severances. Last year’s costs included a $56.0 million charge to increase the Company’s asbestos provision. Excluding these items, administration costs totaled $21.7 million, or 18.4% of sales, in the fourth quarter of fiscal 2024, versus $24.9 million, or 21.6% of sales, in the fourth quarter of fiscal 2023. The decrease is mostly due to lower expenses for the North American operations and cost reduction initiatives throughout the Company’s operations.
EBITDA1 reached $8.5 million compared to negative $39.5 million last year. Excluding asbestos and restructuring costs, adjusted EBITDA was $19.9 million in the fourth quarter of fiscal 2024, compared to $16.5 million a year earlier. This increase reflects lower administration costs and a $1.7 million net reduction in other expenses, mainly related to a provision related to a commodity tax audit last year. These factors were partially offset by a lower gross profit.
Net loss was $2.1 million, or $0.10 per share, versus a net loss of $47.2 million, or $2.18 per share last year. Excluding the after-tax effect of asbestos and restructuring costs, adjusted net income was $8.9 million, or $0.41 per share, compared to $8.8 million, or $0.41 per share, last year. The variation is attributable to higher adjusted EBITDA partially offset by higher net finance costs and income tax expense.
YEAR-END RESULTS
For the fiscal year ended February 29, 2024, sales amounted to $346.8 million, down from $370.4 million last year. Gross profit was $93.2 million, or 26.9% of sales, compared to $112.5 million, or 30.4% of sales, last year. EBITDA stood at $5.3 million, versus negative $34.9 million a year ago, while adjusted EBITDA reached $17.8 million compared to $21.1 million last year. Net loss was $19.7 million, or $0.91 per share, compared to a net loss of $55.5 million, or $2.57 per share, a year ago, while adjusted net loss was $7.9 million, or $0.37 per share, compared to adjusted net income of $0.5 million, or $0.02 per share in the prior year.
FINANCIAL POSITION
As at February 29, 2024, Velan’s financial position remained solid. The Company had cash and cash equivalents of $36.4 million, as well as short-term investments of $5.3 million, while long-term debt, including the current portion, amounted to $28.8 million.
OUTLOOK
Velan aims to build on the momentum gained in the second half of fiscal 2024, concluding the year on a solid note with a growing order backlog and a book-to-bill ratio of 1.08. As at February 29, 2024, orders totaling $360.7 million, representing 73.4% of a total backlog of $491.5 million, are expected to be delivered in the next 12 months. Given these orders, the Company expects to deliver annual sales in fiscal 2025 above the level achieved in fiscal 2024.
CONFERENCE CALL NOTICE
Financial analysts, shareholders, and other interested individuals are invited to attend the fourth quarter conference call to be held on Friday, May 17, 2024, at 8:00 a.m. (EDT). The toll-free call-in number is 1-888-660-6345 or 1-289-819-1450. The material that will be referenced during the conference call will be made available shortly before the event on the company’s website under the Investor Relations section (https://www.velan.com/en/company/investor_relations). A recording of this conference call will be available for seven days at 1-289-819-1450 or 1-888-660-6345, access code 24455.
ABOUT VELAN
Founded in Montreal in 1950, Velan Inc. (www.velan.com) is one of the world’s leading manufacturers of industrial valves, with sales of US$346.8 million in its last reported fiscal year. The Company employs approximately 1,641 people and has manufacturing plants in 9 countries. Velan Inc. is a public company with its shares listed on the Toronto Stock Exchange under the symbol VLN.
SAFE HARBOUR STATEMENT
This news release may include forward-looking statements, which generally contain words like “should”, “believe”, “anticipate”, “plan”, “may”, “will”, “expect”, “intend”, “continue” or “estimate” or the negatives of these terms or variations of them or similar expressions, all of which are subject to risks and uncertainties, which are disclosed in the Company’s filings with the appropriate securities commissions. While these statements are based on management’s assumptions regarding historical trends, current conditions and expected future developments, as well as other factors that it believes are reasonable and appropriate in the circumstances, no forward-looking statement can be guaranteed and actual future results may differ materially from those expressed herein. The Company disclaims any intention or obligation to update or revise any forward-looking statements contained herein whether as a result of new information, future events or otherwise, except as required by the applicable securities laws. The forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
NON-IFRS AND SUPPLEMENTARY FINANCIAL MEASURES
In this press release, the Company has presented measures of performance or financial condition which are not defined under IFRS (“non-IFRS measures”) and are, therefore, unlikely to be comparable to similar measures presented by other companies. These measures are used by management in assessing the operating results and financial condition of the Company and are reconciled with the performance measures defined under IFRS. The Company has also presented supplementary financial measures which are defined at the end of this report. Reconciliation and definition can be found below.
Adjusted net income, Adjusted net income per share, Earnings before interest, taxes, depreciation and amortization ("EBITDA") and Adjusted EBITDA
(thousands, except amount per shares) | Three-month period ended | Fiscal years ended | |||||||
Feb. 29, 2024 | Feb. 28, 2023 | Feb. 29, 2024 | Feb. 28, 2023 | ||||||
$ | $ | $ | $ | ||||||
Reconciliation of net income (loss) to adjusted net income (loss)2& adjusted net income (loss) per share | |||||||||
Net income (loss) | (2,083 | ) | (47,164 | ) | (19,737 | ) | (55,453 | ) | |
Adjustment for: | |||||||||
Proposed transaction related costs | 108 | - | 900 | - | |||||
Restructuring costs | 919 | - | 919 | - | |||||
Adjustment to asbestos provision | 10,000 | 55,954 | 10,000 | 55,954 | |||||
Adjusted net income (loss) | 8,944 | 8,790 | (7,918 | ) | 501 | ||||
per share - basic and diluted | 0.41 | 0.41 | (0.37 | ) | 0.02 | ||||
Reconciliation of net income (loss) to Adjusted EBITDA | |||||||||
Net income (loss) | (2,083 | ) | (47,164 | ) | (19,737 | ) | (55,453 | ) | |
Adjustments for: | |||||||||
Depreciation of property, plant and equipment | 2,472 | 2,452 | 8,930 | 8,722 | |||||
Amortization of intangible assets and financing costs | 650 | 608 | 2,296 | 2,272 | |||||
Finance costs – net | 2,355 | 516 | 6,346 | 1,552 | |||||
Income taxes | 5,088 | 4,102 | 7,471 | 8,045 | |||||
EBITDA | 8,482 | (39,486 | ) | 5,306 | (34,862 | ) | |||
Adjustments for: | |||||||||
Proposed transaction related costs | 147 | - | 1,224 | - | |||||
Restructuring costs | 1,250 | - | 1,250 | - | |||||
Adjustment to asbestos provision | 10,000 | 55,954 | 10,000 | 55,954 | |||||
Adjusted EBITDA | 19,879 | 16,468 | 17,780 | 21,092 |
The term “Adjusted net income (loss)” is defined as net income or loss attributable to Subordinate and Multiple Voting Shares plus adjustment, net of income taxes, for costs related to the proposed transaction, restructuring, and asbestos provision. The terms “Adjusted net income (loss) per share” is obtained by dividing Adjusted net income (loss) by the total amount of subordinate and multiple voting shares. The forward-looking statements contained in this MD&A are expressly qualified by this cautionary statement.
The term “EBITDA” is defined as adjusted net income plus depreciation of property, plant & equipment, plus amortization of intangible assets, plus net finance costs, plus income tax provision. The term “Adjusted EBITDA” is defined as EBITDA plus adjustment for costs related to the proposed transaction, restructuring, and asbestos provision. The forward-looking statements contained in this MD&A are expressly qualified by this cautionary statement.
Definitions of supplementary financial measures
The term “Net new orders” or “bookings” is defined as firm orders, net of cancellations, recorded by the Company during a period. Bookings are impacted by the fluctuation of foreign exchange rates for a given period. The measure provides an indication of the Company’s sales operation performance for a given period as well as well as an expectation of future sales and cash flows to be achieved on these orders.
The term “backlog” is defined as the buildup of all outstanding bookings to be delivered by the Company. The Company’s backlog is impacted by the fluctuation of foreign exchange rates for a given period. The measure provides an indication of the future operational challenges of the Company as well as an expectation of future sales and cash flows to be achieved on these orders.
The term “book-to-bill” is obtained by dividing bookings by sales. The measure provides an indication of the Company’s performance and outlook for a given period.
The forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
Contact: | |
Rishi Sharma, Chief Financial and Administrative Officer | Martin Goulet, M.Sc., CFA |
Velan Inc. | MBC Capital Markets Advisors |
Tel: (438) 817-4430 | Tel.: (514) 731-0000, ext. 229 |
_______________________1 Non-IFRS and supplementary financial measures. Refer to the Non-IFRS and supplementary financial measures section for definitions and reconciliations.2 Net income or loss refer to net income or loss attributable to Subordinate and Multiple Voting Shares.
Consolidated Statements of Financial Position | |||||
(in thousands of U.S. dollars) | |||||
As at | |||||
February 29, | February 28, | ||||
2024 | 2023 | ||||
$ | $ | ||||
Assets | |||||
Current assets | |||||
Cash and cash equivalents | 36,445 | 50,513 | |||
Short-term investments | 5,271 | 37 | |||
Accounts receivable | 119,914 | 121,053 | |||
Income taxes recoverable | 6,132 | 6,195 | |||
Inventories | 208,702 | 202,649 | |||
Deposits and prepaid expenses | 10,421 | 7,559 | |||
Derivative assets | 125 | 107 | |||
387,010 | 388,113 | ||||
Non-current assets | |||||
Property, plant and equipment | 69,918 | 68,205 | |||
Intangible assets and goodwill | 16,543 | 16,153 | |||
Deferred income taxes | 5,193 | 4,663 | |||
Other assets | 729 | 723 | |||
92,383 | 89,744 | ||||
Total assets | 479,393 | 477,857 | |||
Liabilities | |||||
Current liabilities | |||||
Bank indebtedness | - | 260 | |||
Accounts payable and accrued liabilities | 88,230 | 79,408 | |||
Income taxes payable | 1,568 | 2,832 | |||
Customer deposits | 30,396 | 28,201 | |||
Provisions | 14,129 | 16,485 | |||
Derivative liabilities | 26 | 299 | |||
Current portion of long-term lease liabilities | 1,607 | 1,298 | |||
Current portion of long-term debt | 24,431 | 8,177 | |||
160,387 | 136,960 | ||||
Non-current liabilities | |||||
Long-term lease liabilities | 11,036 | 9,458 | |||
Long-term debt | 4,346 | 21,719 | |||
Income taxes payable | 2,325 | 933 | |||
Deferred income taxes | 3,462 | 3,966 | |||
Customer deposits | 35,082 | 27,937 | |||
Provisions | 74,058 | 70,924 | |||
Other liabilities | 5,438 | 5,125 | |||
135,747 | 140,062 | ||||
Total liabilities | 296,134 | 277,022 | |||
Total equity | 183,259 | 200,835 | |||
Total liabilities and equity | 479,393 | 477,857 |
Consolidated Statements of Loss | ||||||||||
(in thousands of U.S. dollars, excluding number of shares and per share amounts) | ||||||||||
Three-month periods ended | Fiscal years ended | |||||||||
February 29, | February 28, | February 29, | February 28, | |||||||
2024 | 2023 | 2024 | 2023 | |||||||
$ | $ | $ | $ | |||||||
Sales | 117,894 | 115,141 | 346,816 | 370,429 | ||||||
Cost of sales | 79,510 | 75,196 | 253,609 | 257,964 | ||||||
Gross profit | 38,384 | 39,945 | 93,207 | 112,465 | ||||||
Administration costs | 33,121 | 80,841 | 98,744 | 156,759 | ||||||
Other expense (income) | (91 | ) | 1,700 | 448 | 1,568 | |||||
Operating profit (loss) | 5,354 | (42,596 | ) | (5,985 | ) | (45,862 | ) | |||
Finance income | 64 | 240 | 459 | 467 | ||||||
Finance costs | (2,419 | ) | (758 | ) | (6,805 | ) | (2,019 | ) | ||
Finance costs – net | (2,355 | ) | (518 | ) | (6,346 | ) | (1,552 | ) | ||
Income (loss) before income taxes | 2,999 | (43,114 | ) | (12,331 | ) | (47,414 | ) | |||
Income tax expense | 5,088 | 4,102 | 7,471 | 8,045 | ||||||
Net loss for the period | (2,089 | ) | (47,216 | ) | (19,802 | ) | (55,459 | ) | ||
Net income (loss) attributable to: | ||||||||||
Subordinate Voting Shares and Multiple Voting Shares | (2,083 | ) | (47,164 | ) | (19,737 | ) | (55,453 | ) | ||
Non-controlling interest | (6 | ) | (52 | ) | (65 | ) | (6 | ) | ||
Net loss for the period | (2,089 | ) | (47,216 | ) | (19,802 | ) | (55,459 | ) | ||
Net loss per Subordinate and Multiple Voting Share | ||||||||||
Basic and diluted | (0.09 | ) | (2.18 | ) | (0.91 | ) | (2.57 | ) | ||
Dividends declared per Subordinate and Multiple | - | - | 0.02 | 0.02 | ||||||
Voting Share | (CA$ - | ) | (CA$ - | ) | (CA$0.03 | ) | (CA$0.03 | ) | ||
Total weighted average number of Subordinate and | ||||||||||
Multiple Voting Shares | ||||||||||
Basic and diluted | 21,585,635 | 21,585,635 | 21,585,635 | 21,585,635 |
Consolidated Statements of Comprehensive Loss | ||||||||||
(in thousands of U.S. dollars) | ||||||||||
Three-month periods ended | Fiscal years ended | |||||||||
February 29, | February 28, | February 29, | February 28, | |||||||
2024 | 2023 | 2024 | 2023 | |||||||
$ | $ | $ | $ | |||||||
Comprehensive loss | ||||||||||
Net loss for the period | (2,089 | ) | (47,216 | ) | (19,802 | ) | (55,459 | ) | ||
Other comprehensive income (loss) | ||||||||||
Foreign currency translation | (719 | ) | 1,423 | 2,516 | (8,985 | ) | ||||
Comprehensive loss | (2,808 | ) | (45,793 | ) | (17,286 | ) | (64,444 | ) | ||
Comprehensive income (loss) attributable to: | ||||||||||
Subordinate Voting Shares and Multiple Voting Shares | (2,802 | ) | (45,741 | ) | (17,221 | ) | (64,438 | ) | ||
Non-controlling interest | (6 | ) | (52 | ) | (65 | ) | (6 | ) | ||
Comprehensive loss | (2,808 | ) | (45,793 | ) | (17,286 | ) | (64,444 | ) | ||
Other comprehensive loss is composed solely of items that may be reclassified subsequently to the consolidated statement of loss. |
Consolidated Statements of Changes in Equity | |||||||||||||||
(in thousands of U.S. dollars, excluding number of shares) | |||||||||||||||
Equity attributable to the Subordinate and Multiple Voting shareholders | |||||||||||||||
Share capital | Contributedsurplus | Accumulatedothercomprehensiveloss | Retainedearnings | Total | Non-controllinginterest | Total equity | |||||||||
Balance - February 28, 2022 | 72,695 | 6,260 | (32,126 | ) | 217,995 | 264,824 | 686 | 265,510 | |||||||
Net loss for the year | - | - | - | (55,453 | ) | (55,453 | ) | (6 | ) | (55,459 | ) | ||||
Other comprehensive loss | - | - | (8,985 | ) | - | (8,985 | ) | - | (8,985 | ) | |||||
Comprehensive loss | - | - | (8,985 | ) | (55,453 | ) | (64,438 | ) | (6 | ) | (64,444 | ) | |||
Acquisition of non-controlling interests | - | - | - | - | - | 266 | 266 | ||||||||
Other | - | - | (97 | ) | 97 | - | - | - | |||||||
Dividends | |||||||||||||||
Multiple Voting Shares | - | - | - | (366 | ) | (366 | ) | - | (366 | ) | |||||
Subordinate Voting Shares | - | - | - | (131 | ) | (131 | ) | - | (131 | ) | |||||
Balance - February 28, 2023 | 72,695 | 6,260 | (41,208 | ) | 162,142 | 199,889 | 946 | 200,835 | |||||||
Net loss for the year | - | - | - | (19,737 | ) | (19,737 | ) | (65 | ) | (19,802 | ) | ||||
Other comprehensive loss | - | - | 2,516 | - | 2,516 | - | 2,516 | ||||||||
Comprehensive loss | - | - | 2,516 | (19,737 | ) | (17,221 | ) | (65 | ) | (17,286 | ) | ||||
Acquisition of non-controlling interests | - | - | - | - | - | 201 | 201 | ||||||||
Dividends | |||||||||||||||
Multiple Voting Shares | - | - | - | (354 | ) | (354 | ) | - | (354 | ) | |||||
Subordinate Voting Shares | - | - | - | (137 | ) | (137 | ) | - | (137 | ) | |||||
Non-controlling interest | - | - | - | - | - | - | - | ||||||||
Balance - February 29, 2024 | 72,695 | 6,260 | (38,692 | ) | 141,914 | 182,177 | 1,082 | 183,259 |
Consolidated Statements of Cash Flow | ||||||||||
(in thousands of U.S. dollars) | ||||||||||
Three-month periods ended | Fiscal years ended | |||||||||
February 29, | February 28, | February 29, | February 28, | |||||||
2024 | 2023 | 2024 | 2023 | |||||||
$ | $ | $ | $ | |||||||
Cash flows from | ||||||||||
Operating activities | ||||||||||
Net loss for the period | (2,089 | ) | (47,216 | ) | (19,802 | ) | (55,459 | ) | ||
Adjustments to reconcile net loss to cash provided by operating activities | 12,669 | 64,794 | 14,289 | 67,553 | ||||||
Changes in non-cash working capital items | 9,069 | 911 | 9,814 | (11,572 | ) | |||||
Cash provided by operating activities | 19,649 | 18,489 | 4,301 | 522 | ||||||
Investing activities | ||||||||||
Short-term investments | (5,254 | ) | 9,367 | (5,232 | ) | 8,250 | ||||
Additions to property, plant and equipment | (2,925 | ) | (1,385 | ) | (6,829 | ) | (4,370 | ) | ||
Additions to intangible assets | (1,199 | ) | (903 | ) | (2,358 | ) | (2,219 | ) | ||
Proceeds on disposal of property, plant and equipment | (127 | ) | 141 | (45 | ) | 185 | ||||
Net change in other assets | 317 | (117 | ) | 347 | (87 | ) | ||||
Cash provided (used) by investing activities | (9,198 | ) | 7,103 | (14,127 | ) | 1,759 | ||||
Financing activities | ||||||||||
Dividends paid to Subordinate and Multiple Voting shareholders | - | - | (491 | ) | (497 | ) | ||||
Acquisition of non-controlling interests | 1 | 266 | 201 | 266 | ||||||
Net change in revolving credit facility | - | (5,373 | ) | 5,000 | - | |||||
Increase in long-term debt | 1,286 | 1,506 | 1,286 | 3,666 | ||||||
Repayment of long-term debt | (1,069 | ) | (683 | ) | (8,762 | ) | (4,398 | ) | ||
Repayment of long-term lease liabilities | (603 | ) | (566 | ) | (1,895 | ) | (1,657 | ) | ||
Cash provided (used) by financing activities | (385 | ) | (4,850 | ) | (4,661 | ) | (2,620 | ) | ||
Effect of exchange rate differences on cash | 17 | 200 | 679 | (2,873 | ) | |||||
Net change in cash during the period | 10,083 | 20,942 | (13,808 | ) | (3,212 | ) | ||||
Net cash – Beginning of the period | 26,362 | 29,311 | 50,253 | 53,465 | ||||||
Net cash – End of the period | 36,445 | 50,253 | 36,445 | 50,253 | ||||||
Net cash is composed of: | ||||||||||
Cash and cash equivalents | 36,445 | 50,513 | 36,445 | 50,513 | ||||||
Bank indebtedness | - | (260 | ) | - | (260 | ) | ||||
Net cash – End of the period | 36,445 | 50,253 | 36,445 | 50,253 | ||||||
Supplementary information | ||||||||||
Interest paid | (845 | ) | (524 | ) | (1,274 | ) | (974 | ) | ||
Income taxes paid | (2,523 | ) | (1,361 | ) | (6,708 | ) | (8,160 | ) |
1 Year Velan Chart |
1 Month Velan Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions